Magical Trade
Sunday, May 22, 2022
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Johnson & Johnson Stock Jumps on Reports It Plans to Split In Two

by
November 12, 2021
in Trade News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter
Text size

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California

Mark Ralston/AFP via Getty Images


Johnson & Johnson

announced plans on Friday to split from its consumer health division, spelling the end of the last great pharmaceutical conglomerate.

Johnson & Johnson (ticker: JNJ) shares were up on the news, which comes two months before a planned CEO transition, in which longtime Johnson & Johnson executive Joaquin Duato is slated to replace Alex Gorsky in the top post.

RELATED POSTS

Suze Orman says you can avoid 5 common mistakes people make in a stock market crisis

Which beaten down stocks should I buy for the biggest long-term upside? Here are 3 high-growth tech ideas hitting fresh 52-week lows

Johnson & Johnson said that the split will take 18 to 24 months. The consumer health division, which the company said is expected to generate $15 billion in revenue this year, will become a new publicly traded company, selling big-name brands home health brands like Band-Aid, Tylenol, and Listerine.

The pharmaceutical and medical devices divisions, which the company expects to generate revenue of $77 billion this year, will stay behind as a separate company, selling a range of treatments and devices, from balloons used in sinus procedures to bladder cancer therapies. Johnson & Johnson has chosen not to split those two business segments.

Today, with a market value of $432.5 billion, Johnson & Johnson is the largest pharmaceutical company in the world. Johnson & Johnson says that the stay-behind pharmaceutical and medical device business will remain the biggest pharmaceutical company in the world.

Johnson & Johnson stock was up 4.9% in premarket trading Friday, while

S&P 500
futures had advanced 0.2% and

Dow Jones Industrial Average
futures had risen 0.2%.

Johnson & Johnson has become something of an anachronism in recent years, as its competitors have shed their consumer health divisions one after another.


Pfizer

(PFE) handed its consumer health business to


GlaxoSmithKline

(GSK) in 2019; Glaxo is planning on spinning off the combined business soon.

The market has taken time to warm up to those deals.

Johnson & Johnson would be the third company with plans to break up that were revealed this week. General Electric (GE) said it will break itself up into three parts, while


Toshiba

has said it plans to split up as well.

Write to Ben Levisohn at ben.levisohn@barrons.com

ShareTweetPin

Related Posts

Suze Orman says you can avoid 5 common mistakes people make in a stock market crisis

by
May 22, 2022
0

Motley Fool 2 Top Electric Vehicle Stocks to Buy for the Long Haul Tesla (NASDAQ: TSLA) is the undisputed EV...

Which beaten down stocks should I buy for the biggest long-term upside? Here are 3 high-growth tech ideas hitting fresh 52-week lows

by
May 22, 2022
0

Motley Fool Market Plunge: 1 Stock-Split Stock to Buy Now and Hold Forever In recent months, several investor-favorite stocks have...

First baby formula shipment arrives from Europe on U.S. military plane

by
May 22, 2022
0

A military cargo plane carrying the first shipment of infant formula from Europe to address a critical shortage in the...

Conditions Are Ripe for a Deep Bear Market

by
May 22, 2022
0

Previous bear markets have bottomed out when the Federal Reserve eased monetary policy. Photo: JOSHUA ROBERTS/REUTERS With the S&P 500...

Quarterly Starts by Purpose and Design: "Built for rent" Increasing

by
May 22, 2022
0

by Calculated Risk on 5/22/2022 11:48:00 AM Along with the monthly housing starts for April last week, the Census Bureau...

Next Post

Stocks making the biggest moves premarket: Johnson & Johnson, Rivian, Lordstown and more

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • ‘Conviction sell’: UBS says avoid these global stocks amid rising headwinds

    0 shares
    Share 0 Tweet 0
  • These are the global stocks to own if stagflation hits, according to Credit Suisse

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net